Valeant’s Drug Price Strategy Enriches It, but Infuriates Patients and Lawmakers – New York Times


New York Times
Valeant’s Drug Price Strategy Enriches It, but Infuriates Patients and Lawmakers
New York Times
J. Michael Pearson has become a billionaire from his tough tactics as the head of the fast-growing Valeant Pharmaceuticals International. And consumers like Bruce Mannes, a 68-year-old retired carpenter from Grandville, Mich., are facing the consequences.

and moreĀ >>

Source: pharmaceutical – Google News

Sharing information is key – Pharmaceutical Business News UK. Social Commerce and Social Media Management playing a big part. Suaju Ltd